Day: August 13, 2026

Over the years, the FDA has published several highly targeted series of iterations on formal PDUFA interactions, beginning with foundational frameworks under FDAMA in 2000, progressing through major updates in 2017 and 2018, and evolving into draft revisions in late 2023. The latest guidance released this week discusses important procedural and logistical preferences of the … Read more

Imagine scrolling through a slick betting app, placing a quick wager on an Oscar winner, and then sliding over to bet on whether a childhood cancer drug will pass its final clinical trial. This isn’t a speculative dystopian concept; it is the current reality offered by platforms like Kalshi and Polymarket, which now allow users … Read more